Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.68
0.081.21%
At close: Jan 16, 4:00 PM EST
$6.81
0.131.95%
After Hours: Jan 16, 4:45 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Verastem (VSTM) stock?
You can purchase shares of Verastem (NASDAQ:VSTM) through any online brokerage.
Who are Verastem (VSTM) competitors?
Other companies in Verastem’s space includes: Monopar Therapeutics Inc (NASDAQ:MNPR), Replimune Group Inc (NASDAQ:REPL), Altimmune Inc (NASDAQ:ALT), Prothena Corp PLC (NASDAQ:PRTA) and DiaMedica Therapeutics Inc (NASDAQ:DMAC).
What is the forecast, or price target, for Verastem (VSTM) stock?
Verastem has a consensus price target of $16.00.
What is the current price for Verastem (VSTM)?
The stock price for Verastem (NASDAQ: VSTM) is $6.81 last updated January 16, 2026 at 4:45 PM EST.
Does Verastem (VSTM) pay a dividend?
There are no upcoming dividends for Verastem.
When is Verastem (NASDAQ:VSTM) reporting earnings?
Verastem does not have any upcoming earnings scheduled.
Is Verastem (VSTM) going to split?
There is no upcoming split for Verastem.
What sector and industry does Verastem (VSTM) operate in?
Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
